IS1639B - Hliðstæð aðferð til að framleiða ný antihistamín,sem ekki hafa róandi áhrif, leidd af benzimidazole efnum - Google Patents

Hliðstæð aðferð til að framleiða ný antihistamín,sem ekki hafa róandi áhrif, leidd af benzimidazole efnum

Info

Publication number
IS1639B
IS1639B IS3832A IS3832A IS1639B IS 1639 B IS1639 B IS 1639B IS 3832 A IS3832 A IS 3832A IS 3832 A IS3832 A IS 3832A IS 1639 B IS1639 B IS 1639B
Authority
IS
Iceland
Prior art keywords
radical
alkyl
hydroxyl
derived
aryl
Prior art date
Application number
IS3832A
Other languages
English (en)
Other versions
IS3832A (is
Inventor
Rosa Cuberes-Altisent Maria
Frigola Constansa Jordi
Pares Corominas Juan
Original Assignee
Laboratorios Del Dr. Esteve, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Del Dr. Esteve, S.A. filed Critical Laboratorios Del Dr. Esteve, S.A.
Publication of IS3832A publication Critical patent/IS3832A/is
Publication of IS1639B publication Critical patent/IS1639B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Anesthesiology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IS3832A 1991-04-05 1992-04-02 Hliðstæð aðferð til að framleiða ný antihistamín,sem ekki hafa róandi áhrif, leidd af benzimidazole efnum IS1639B (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9104171A FR2674856B1 (fr) 1991-04-05 1991-04-05 Nouveaux antihistaminiques non sedatifs, derives de benzimidazole, leur procede de preparation et leur utilisation en tant que medicaments.

Publications (2)

Publication Number Publication Date
IS3832A IS3832A (is) 1992-10-06
IS1639B true IS1639B (is) 1997-03-25

Family

ID=9411523

Family Applications (1)

Application Number Title Priority Date Filing Date
IS3832A IS1639B (is) 1991-04-05 1992-04-02 Hliðstæð aðferð til að framleiða ný antihistamín,sem ekki hafa róandi áhrif, leidd af benzimidazole efnum

Country Status (28)

Country Link
US (1) US5214040A (is)
EP (1) EP0507696B1 (is)
JP (1) JP3060054B2 (is)
KR (1) KR970011298B1 (is)
CN (1) CN1028367C (is)
AT (1) ATE126228T1 (is)
AU (1) AU647904B2 (is)
BG (1) BG60678B1 (is)
BR (1) BR1100983A (is)
CA (1) CA2065061A1 (is)
CZ (1) CZ279506B6 (is)
DE (1) DE69203911T2 (is)
DK (1) DK0507696T3 (is)
ES (1) ES2046110B1 (is)
FI (1) FI99112C (is)
FR (1) FR2674856B1 (is)
GR (1) GR3017643T3 (is)
HU (1) HU214316B (is)
IL (1) IL101483A (is)
IS (1) IS1639B (is)
MX (1) MX9201556A (is)
NO (1) NO179552C (is)
NZ (1) NZ242208A (is)
PL (1) PL167720B1 (is)
RO (1) RO109198B1 (is)
RU (1) RU2099336C1 (is)
TW (1) TW208003B (is)
YU (1) YU48826B (is)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264456B1 (it) * 1993-05-14 1996-09-23 Dompe Farmaceutici Spa Derivati del 2-(benzimidazol-2-il)-1,3-diaminopropano farmacologicamente attivi.
FR2727865B1 (fr) * 1994-12-08 1997-07-18 Esteve Labor Dr Utilisation des derives de 2-(4-(azolybutyl)-piperazinyl- (methyl))-benzimidazole et analogues ainsi que de leurs sels, pour la preparation de medicaments destines au traitement ou a la prophylaxie de l'asthme
US5773616A (en) * 1995-02-15 1998-06-30 Neurogen Corporation Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands
WO1996025411A1 (en) * 1995-02-15 1996-08-22 Neurogen Corporation Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands
FR2731618B1 (fr) * 1995-03-14 1997-08-01 Esteve Labor Dr Composition ophtalmique topique comprenant un derive de 2-(4-(azolylbutyl)-piperazinyl-methyl)-benzimidazole, notamment pour le traitement de la conjonctivite allergique
US6211199B1 (en) 1995-11-17 2001-04-03 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
US6194406B1 (en) 1995-12-20 2001-02-27 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease
US6423704B2 (en) 1995-12-20 2002-07-23 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases
US5998439A (en) * 1996-02-21 1999-12-07 Hoescht Marion Roussel, Inc. Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
US5922737A (en) * 1996-02-21 1999-07-13 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases
US5932571A (en) * 1996-02-21 1999-08-03 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) {1,4}diazepan-1-yl)-2-(aryl) butyl) benzamides useful for the treatment of allergic diseases
WO1999061013A2 (en) * 1998-05-22 1999-12-02 Avanir Pharmaceuticals COMPOUNDS HAVING IgE AFFECTING PROPERTIES
TWI225488B (en) * 1999-12-21 2004-12-21 Janssen Pharmaceutica Nv Derivatives of homopiperidinyl substituted benzimidazole analogues
CZ304346B6 (cs) * 2000-01-19 2014-03-19 Cadila Healthcare Ltd. Substituovaný pyrrolový derivát s hypolipidemickou hypocholesteremickou aktivitou, způsob jeho přípravy a farmaceutický přípravek obsahující tyto sloučeniny
ES2554105T3 (es) * 2000-10-31 2015-12-16 Basf Se Uso de poliuretanos hiperramificados para la preparación de tintas de impresión
RU2303038C2 (ru) * 2001-02-02 2007-07-20 Бристол-Маерс Сквибб Компани Азаиндолоксоуксусные производные пиперазины и фармацевтическая композиция на их основе
EP1465635A4 (en) * 2002-01-10 2005-04-13 Neurogen Corp MELANIN-CONCENTRATING HORMONIC RECEPTOR LIGANDS: SUBSTITUTED 2- (4-BENZYL-PIPERAZIN-1-YLMETHYL) AND 2- (4-BENZYL-DIAZEPAN-1-YLMETHYL) -1H-BENZOIMIDAZOLE ANALOGUES
RU2288917C2 (ru) * 2002-04-19 2006-12-10 Фаэс Фарма, С.А. Полиморф 4-[2-[4-[1-(2-этоксиэтил)-1h-бензимидазол-2-ил]-1-пиперидинил]этил]-альфа, альфа-диметилбензолуксусной кислоты, способ его получения, фармацевтический препарат на его основе и его применение
DK1784404T3 (da) * 2004-09-03 2012-02-13 Yuhan Corp Pyrrolo[2,3-c]pyridinderivater samt fremgangsmåder til deres fremstilling
CN101089000B (zh) 2006-06-16 2011-01-05 北京大学 螺环哌嗪季铵盐类化合物及其制备方法和应用
MX2011013294A (es) * 2009-06-11 2012-01-12 Siena Biotech Spa Antagonistas de la trayectoria de hedgehog y aplicaciones terapeuticas de los mismos.
ES2605494T3 (es) * 2012-12-27 2017-03-14 Alzprotect Sales de sulfato de N-(3-(4-(3-(diisobutilamino)propil)piperazin-1-il)propil)-1H-benzo[d]imidazol-2-amina, preparación y uso de las mismas

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200641A (en) * 1976-12-21 1980-04-29 Janssen Pharmaceutica, N.V. 1-[(Heterocyclyl)-alkyl]-4-diarylmethoxy piperidine derivatives
DE3336409A1 (de) * 1983-10-06 1985-04-18 Ludwig Heumann & Co GmbH, 8500 Nürnberg Chinazolinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US5010075A (en) * 1987-04-24 1991-04-23 Syntex Pharmaceuticals Ltd. Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives
CA1317939C (en) * 1987-07-01 1993-05-18 Janssen Pharmaceutica Naamloze Vennootschap ¬(bicyclic heterocyclyl)methyl and -hetero| substituted hexahydro-1h-azepines and pyrrolidines
FR2665161B1 (fr) * 1990-07-26 1992-11-27 Esteve Labor Dr Nouveaux derives de benzimidazole, leur preparation et leur application en tant que medicaments.

Also Published As

Publication number Publication date
ATE126228T1 (de) 1995-08-15
HUT60732A (en) 1992-10-28
CZ279506B6 (cs) 1995-05-17
DE69203911T2 (de) 1995-12-07
BG96180A (bg) 1993-12-24
NO179552B (no) 1996-07-22
AU1397992A (en) 1992-10-08
PL294101A1 (en) 1992-11-30
IS3832A (is) 1992-10-06
FR2674856B1 (fr) 1993-07-30
FI99112C (fi) 1997-10-10
BG60678B1 (bg) 1995-12-29
RO109198B1 (ro) 1994-12-30
RU2099336C1 (ru) 1997-12-20
FI921473L (fi) 1992-10-06
YU33692A (sh) 1995-03-27
CA2065061A1 (fr) 1992-10-06
AU647904B2 (en) 1994-03-31
HU9201145D0 (en) 1992-06-29
FI921473A0 (fi) 1992-04-03
NZ242208A (en) 1993-10-26
NO921315L (no) 1992-10-06
HU214316B (hu) 1998-03-02
ES2046110B1 (es) 1994-08-01
MX9201556A (es) 1992-10-01
DK0507696T3 (da) 1995-09-18
PL167720B1 (pl) 1995-10-31
CN1028367C (zh) 1995-05-10
EP0507696B1 (fr) 1995-08-09
IL101483A0 (en) 1992-12-30
TW208003B (is) 1993-06-21
CN1065460A (zh) 1992-10-21
YU48826B (sh) 2002-03-18
FI99112B (fi) 1997-06-30
JP3060054B2 (ja) 2000-07-04
ES2046110A1 (es) 1994-01-16
NO921315D0 (no) 1992-04-03
IL101483A (en) 1995-12-08
EP0507696A1 (fr) 1992-10-07
JPH0597846A (ja) 1993-04-20
KR920019781A (ko) 1992-11-20
NO179552C (no) 1996-10-30
KR970011298B1 (ko) 1997-07-09
CS101792A3 (en) 1992-10-14
GR3017643T3 (en) 1996-01-31
DE69203911D1 (de) 1995-09-14
US5214040A (en) 1993-05-25
BR1100983A (pt) 1999-10-13
FR2674856A1 (fr) 1992-10-09

Similar Documents

Publication Publication Date Title
IS3832A (is) Hliðstæð aðferð til að framleiða ný antihistamín,sem ekki hafa róandi áhrif, leidd af benzimidazole efnum
CY1110240T1 (el) Νεα παραγωγα 2η-πυριδαζινο-3-ονης, φαρμακευτικες συνθεσεις που τα περιεχουν και μεθοδος για την παρασκευη του δραστικου συστατικου
NZ336302A (en) Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of benign prostatic hyperplasia
ATE109481T1 (de) Diazinderivate als angiotensin ii rezeptor antagonisten.
DK0468884T5 (da) Hidtil ukendte benzimidazolderivater, fremstilling heraf og anvendelse af disse som medikamenter
DE69407407D1 (de) Ampa antagonisten und behandlungsmethode
HUP0001165A2 (hu) NK1 és NK2 antagonista hatású acil-amino-alkil-amid-származékok, a vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra
FI930236A0 (fi) Bensimidazoler, dessa foereningar innehaollande laekemedel och foerfarandefoer deras framstaellning
DK0556813T3 (da) Amfotere tricykliske forbindelser som antihistaminske og antiallergiske midler
ATE402940T1 (de) Verfahren zur herstellung von 3-cephem- verbindungen
ES2140552T3 (es) Derivados indol como inhibidores de la 5-alfa-reductasa-1.
KR970706280A (ko) 5-HT1A 길항제로서의 비사이클릭 카복스아미드(Bicyclic carboxamides as 5-HT1 antagonists)
ATE154010T1 (de) 2-phenyl- und 2-thienyl-(2)-piperidinderivate mit neuroprotektiven eigenschaften
NZ221004A (en) 2,6-piperazinediones and pharamceutical compositions